Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Evaluation of Immunologic Response following COVID-19 Vaccination in Children, Adolescents, and Young Adults with Cancer
Pediatrics
Pediatrics
This study evaluates immunologic response following COVID-19 vaccination in children, adolescents, and young adults with cancer. Vaccines work by stimulating the bodys immune cells to respond against a specific disease. The immune response produces protection from that disease. Effects from cancer and from treatments for cancer can reduce the bodys natural disease fighting ability (called immunity). Factors such as vaccine type, timing of vaccine dosing related to treatment for cancer and number of vaccine doses or boosts (extra vaccine shots) may strengthen or diminish the bodys protective immune response. This study may help researchers learn more about how the bodys immune system responds to the COVID-19 vaccine when the vaccination is given during or after cancer treatment.
Pediatrics
N/A
Esbenshade, Adam
NCT05228275
COGACCL21C2
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Multiple Cancer Types
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Lymphoma,
Miscellaneous,
Pediatric Solid Tumors
N/A
Borinstein, Scott
NCT03155620
COGAPEC1621SC
ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders
Not Available
IV
Wheeler, Allison
NCT04398628
NCBH2303-TRANSCENDS
REACH (Research, Education, Advocacy, Clinical Care and Health) for Survivorship Program: Long Term Effects for Survivors of Cancer
Multiple Cancer Types
Miscellaneous,
Pediatrics
N/A
Esbenshade, Adam
VICCPED0710
Severe Chronic Neutropenia International Registry
Benign Hematologic
Benign Hematologic
Benign Hematologic
N/A
McDaniel, Heather
VICCNCPED10104
Hematologic Malignancy Tumor Bank
Multiple Cancer Types
Hematologic,
Leukemia,
Lymphoma
N/A
Seegmiller, Adam
VICCHEM1217
Mount Sinai Acute Graft-versus-Host Disease International Consortium (MAGIC): A Database and Biorepository
Miscellaneous
Miscellaneous
Miscellaneous
N/A
Kitko, Carrie
VICCPED1544
The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Miscellaneous
Miscellaneous
Miscellaneous
N/A
Friedman, Debra
COGAPEC14B1
A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)
Hematologic
Hematologic
Hematologic
N/A
Wheeler, Allison
VICCNCBH19121
